학술논문
Older adults with newly diagnosed high-risk/secondary AML who achieved remission with CPX-351: phase 3 post hoc analyses
Document Type
Article
Author
Source
In Blood Advances 23 March 2021 5(6):1719-1728
Subject
Language
ISSN
2473-9529